Skip to content
Medical Health Aged Care

Monash Expert: Senate report on assessment and support services for people with ADHD

Monash University 2 mins read

The Senate inquiry into assessment and support services for people with ADHD (attention deficit hyperactive disorder) has handed down its report.  

It found cost, location, cultural and gendered barriers to access and called for national consistency in diagnosis and treatment to improve the lives of those with the condition. 

Available to comment: 

Professor Mark Bellgrove, Deputy Head of School (Research), Monash University School of Psychological Sciences and Turner Institute for Brain and Mental Health; Director and Lead, Australian Evidence-Based Clinical Practice Guideline for ADHD, Australian ADHD Professionals Association (AADPA)
Contact details: +61, 0430 421 234 or [email protected]  
Read more of Professor Belgrove’s commentary at Monash Lens 

  • What ADHD is
  • ADHD diagnosis
  • Latest treatment and guidelines
  • Barriers to effective treatment

The following can be attributed to Professor Bellgrove:

“The Senate Inquiry into Assessment and Support Services for People with ADHD is a landmark moment where the voices of both Australians with a lived experience and professionals involved in care, have been heard. The 15 recommendations are appropriate, practical and formulated with due consideration to both the evidence and the needs of consumers. 

“As a Director of the Australian ADHD Professionals Association (AADPA), and Lead for the development of Australia's ADHD Clinical Practice Guideline, I am delighted that our call for both a National Framework for ADHD (recommendation #1) and funding for the implementation of the ADHD Clinical Practice Guideline (recommendation #13) are put forward as recommendations for the Australian Government to consider. 

“I am also very pleased to see recommendations (#8) encouraging neurodiversity-affirming campaigns to actively shift social attitudes and reduce stigma.” 

Professor Bellgrove was the AADPA lead in the development of Australia's first NHMRC-approved Clinical Practice Guideline for ADHD and gave evidence at the Senate inquiry. The feasibility of implementation of the Guideline was listed within the terms of reference of the Senate inquiry and Recommendation 13 in the released report recommends that the Government consider investing in its implementation. 

For more Monash media stories visit our news & events site: monash.edu/news
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or [email protected]

More from this category

  • Medical Health Aged Care, Women
  • 08/03/2026
  • 07:00
Monash University

What women really want re their health – and why they can’t always get it

What women really want re their health – and why they can’t always get it The most comprehensive study of the health conditions and social issues affecting women and girls in Australia has just been published by Monash University researchers and The Sisterhood Foundation. It reveals that women’s and girls’ health is often overlooked, underfunded, and misunderstood. The study found that the health system, researchers and the media mostly think about women’s health in terms of their reproductive health. However, there is a need to go ‘beyond the bikini line’ and focus on all aspects of women’s and girls’ health…

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

  • Medical Health Aged Care
  • 06/03/2026
  • 15:57
Dementia Australia

Cronulla comes together for people impacted by dementia

Friday 6 March 2026 Cronulla comes together for people impacted by dementia Cronulla community members tied up their laces and showed up in force last weekend for the 2026 Cronulla Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 760 people walked, ran and jogged to the finish line to raise an impressive total of $103,430. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Cronulla community…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.